/
BIOGF
$0.66-$0.50 (-43.10%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change$-0.53
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $37.4M | $43.1M | $48.3M | $57.5M |
| Cost of revenue | $21.3M | $26.3M | $33.9M | $29.8M |
| Gross profit | $16.1M | $16.8M | $14.3M | $27.7M |
| Gross margin | 43.0% | 39.1% | 29.7% | 48.2% |
| R&D | $39.8M | $40.9M | $48.1M | $38.4M |
| Operating income | −$55.6M | −$46.9M | −$62.6M | −$47.0M |
| EBITDA | −$47.3M | −$43.2M | −$52.5M | −$44.0M |
| Net income | −$64.1M | −$62.9M | −$71.5M | −$65.4M |
| Net margin | -171.1% | -145.9% | -148.1% | -113.7% |
| EPS (diluted) | -1.14 | -1.11 | -1.24 | -1.08 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds BIOGF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOGF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOGF yet.